Been doing some digging on the drug Tocilizumab discussed a few breads ago. It’s a drug being treated for C19 but there is a massive shortage of it.
“The Swiss pharmaceutical major Roche has a complete monopoly over who makes this drug. Currently, only Roche and its subsidiary Genentech make it. Roche has not licensed it out to any other company.”
https://fit.thequint.com/coronavirus/life-saving-covid-19-drug-tocilizumab-scarcity-price-hike#:~:text=The%20main%20reason%20for%20this%20is%20that%20the,distributed%20by%20the%20Indian%20generic%20drug%20company%20Cipla.#read-more
Dig into the parent company, here are the major investors. Do any of them ring a bell?
https://stockzoa.com/ticker/rhhby/